Dr. Daniel Benhuri, MD

Dr. Benhuri practices at The Rehabilitation Centre of Beverly Hills in Los Angeles, California.

Dr. Benhuri's NPI, 1003304189, was assigned on April 25, 2018. Dr. Benhuri graduated from University of Toledo College of Medicine and Life Sciences in 2018. Dr. Benhuri holds California license A174435.

Dr. Benhuri's primary practice is The Rehabilitation Centre of Beverly Hills, at 580 S San Vicente Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (323) 782-1500.

Dr. Benhuri's primary practice is The Rehabilitation Centre of Beverly Hills in Los Angeles, California. Dr. Benhuri is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Inpatient Specialist of California PC. Dmand AI also links Dr. Benhuri to 4 more medical groups, 3 group practices and clinics, 3 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benhuri practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Benhuri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Benhuri is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Benhuri's licenses on file in 2 states: California and New York.

Dmand AI lists arthritis, chronic diabetes, enlarged thyroid and testicular dysfunction among the conditions Dr. Benhuri treats.

CMS data shows 874 Medicare services from Dr. Benhuri across 14 procedure codes in 2024, for 104 Medicare patients. Medicare paid $71,833 for them. Every service was in an office.

CMS counts 104 Medicare patients who saw Dr. Benhuri in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Benhuri's median patient age at 37, with 54% women.

In 2024, Dr. Benhuri wrote 994 Medicare Part D claims for 76 patients. 80% of them were for generic drugs. CMS names the drug for 470 of them, across 24 drugs with 11 or more claims each, at $69,504 in total drug cost. In 2023, CMS named 236 claims across 13 drugs.

Dr. Benhuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benhuri as offering telehealth.

Dmand AI links 5 papers to Dr. Benhuri in 2021. 2021 was the busiest year, with 3. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Benhuri's most frequent co-authors are Stamatios Lerakis, MD, Cheguevara I. Afaneh, MD and Frans Joseph Beerkens, MD.

CMS Open Payments shows 162 general payments to Dr. Benhuri from 30 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 96% of the total. Eli Lilly and Company paid the most, $921.

Dr. Benhuri graduated from University of Toledo College of Medicine and Life Sciences in 2018.

Dr. Benhuri is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.